Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease–substrate interaction

[1]  C. James,et al.  Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. , 2001, Human gene therapy.

[2]  R. Bast,et al.  Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. , 2001, Gynecologic oncology.

[3]  G. Gores,et al.  Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy. , 2000, Cancer research.

[4]  R. Vile,et al.  A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy , 2000, Gene Therapy.

[5]  Stephen J. Weiss,et al.  Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3 , 2000, The Journal of cell biology.

[6]  S. Russell,et al.  A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display. , 2000, Human gene therapy.

[7]  R. Vile,et al.  Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. , 2000, Cancer research.

[8]  F. Cosset,et al.  Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors , 1999, Gene Therapy.

[9]  J. Neoptolemos,et al.  The Matrix Metalloproteinases and Their Inhibitors in the Treatment of Pancreatic Cancer , 1999, Annals of the New York Academy of Sciences.

[10]  Y. Okada,et al.  Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. , 1999, The American journal of pathology.

[11]  F. Cosset,et al.  In vivo selection of protease cleavage sites from retrovirus display libraries , 1998, Nature Biotechnology.

[12]  H. Peter,et al.  Copyright © American Society for Investigative Pathology Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Human Brain Tumors , 2022 .

[13]  F. Cosset,et al.  Masking of retroviral envelope functions by oligomerizing polypeptide adaptors. , 1997, Virology.

[14]  J. Chen,et al.  Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer , 1997, Gene Therapy.

[15]  Y. Okada,et al.  Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. , 1997, Cancer research.

[16]  F. Cosset,et al.  A gene delivery system activatable by disease-associated matrix metalloproteinases. , 1997, Human gene therapy.

[17]  J. Uhm,et al.  Glioma invasionin vitro: regulation by matrix metalloprotease-2 and protein kinase C , 1996, Clinical & Experimental Metastasis.

[18]  G. Butler,et al.  The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.

[19]  L. Liotta,et al.  Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. , 1996, Cancer research.

[20]  D. Hupe,et al.  Reconstructed 19 kDa catalytic domain of gelatinase A is an active proteinase. , 1995, Biochemistry.

[21]  W. Anderson,et al.  The cellular receptor for gibbon ape leukemia virus is a novel high affinity sodium-dependent phosphate transporter. , 1994, The Journal of biological chemistry.

[22]  T. L. Moser,et al.  Secretion of extracellular matrix‐degrading proteinases is increased in epithelial ovarian carcinoma , 1994, International journal of cancer.

[23]  Christopher D. Richardson,et al.  The human CD46 molecule is a receptor for measles virus (Edmonston strain) , 1993, Cell.

[24]  D. Powe,et al.  Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours , 1991, International journal of cancer.

[25]  J. McKerrow,et al.  Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. , 1990, Cancer research.

[26]  J. Uhm,et al.  Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. , 1996, Clinical & experimental metastasis.

[27]  L. Liotta,et al.  Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.

[28]  P. Coleman,et al.  Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. , 1981, Methods in enzymology.